|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Physiology, East Carolina Uninversity, Greenville, NC, USA
2 Department of Exercise and Sport Science, Human Performance Laboratory, East Carolina University, Greenville, NC, USA
3 Department of Physiology, East Carolina Uninversity, Greenville, NC, USA; Department of Exercise and Sport Science, Human Performance Laboratory, East Carolina University, Greenville, NC, USA
4 Department of Anatomy and Cell Biology, East Carolina University, Greenville, NC, USA
5 Department of Surgery, East Carolina University, Greenville, NC, USA
6 Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
* To whom correspondence should be addressed. E-mail: hulverm{at}mail.ecu.edu.
The objectives of this study were to: 1) examine skeletal muscle fatty acid oxidation in individuals with varying degrees of adiposity; and 2) determine the relationship between skeletal muscle fatty acid oxidation and the accumulation of long chain fatty acyl CoAs. Muscle was obtained from normal weight [N=8; body mass index (BMI), 23.8±0.58 kg/m2], overweight/obese (N=8; BMI, 30.2±0.81 kg/m2), and extremely obese (N=8; BMI, 53.8±3.5 kg/m2) females undergoing abdominal surgery. Skeletal muscle fatty acid oxidation was assessed in intact muscle strips. Long chain fatty acyl CoA concentrations were measured in a separate portion of the same muscle tissue in which fatty acid oxidation was determined. Palmitate oxidation was 58% and 83% lower in skeletal muscle from extremely obese (44.9±5.2 nmole/g/h) patients compared to normal weight (71.0±5.0 nmole/g/h) and overweight/obese (82.2±8.7 nmole/g/h), respectively. Palmitate oxidation was negatively (R=-.44, P=.003) associated with BMI. Long chain fatty acyl CoA content was higher in both the overweight/obese and extremely obese patients compared to normal weight, despite significantly lower fatty acid oxidation only in the extremely obese. No associations were observed between long chain fatty acyl CoA content and palmitate oxidation. These data suggest that there is a defect in skeletal muscle fatty acid oxidation with extreme obesity but not overweight/obesity; and that the accumulation of intra-myocellular long chain fatty acyl CoAs are not solely a result of reduced fatty acid oxidation.
This article has been cited by other articles:
![]() |
L. P Turcotte and J. S Fisher Skeletal Muscle Insulin Resistance: Roles of Fatty Acid Metabolism and Exercise Physical Therapy, November 1, 2008; 88(11): 1279 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Berggren, K. E. Boyle, W. H. Chapman, and J. A. Houmard Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E726 - E732. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Thyfault Setting the stage: possible mechanisms by which acute contraction restores insulin sensitivity in muscle Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1103 - R1110. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Houmard Intramuscular lipid oxidation and obesity Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1111 - R1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Thrush, G. J. Heigenhauser, K. L. Mullen, D. C. Wright, and D. J. Dyck Palmitate acutely induces insulin resistance in isolated muscle from obese but not lean humans Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2008; 294(4): R1205 - R1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T Cefalu, J. Ye, A. Zuberi, D. M Ribnicky, I. Raskin, Z. Liu, Z. Q Wang, P. J Brantley, L. Howard, and M. Lefevre Botanicals and the metabolic syndrome Am. J. Clinical Nutrition, February 1, 2008; 87(2): 481S - 487S. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Waring, Y. Yang, C. H. Healan-Greenberg, A. L. Adler, R. Dickinson, T. McNally, X. Wang, M. Weitzberg, X. Xu, A. Lisowski, et al. Gene Expression Analysis in Rats Treated with Experimental Acetyl-Coenzyme A Carboxylase Inhibitors Suggests Interactions with the Peroxisome Proliferator-Activated Receptor {alpha} Pathway J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 507 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Moro, S. Bajpeyi, and S. R. Smith Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E203 - E213. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Heilbronn, S. Gregersen, D. Shirkhedkar, D. Hu, and L. V. Campbell Impaired Fat Oxidation After a Single High-Fat Meal in Insulin-Sensitive Nondiabetic Individuals With a Family History of Type 2 Diabetes Diabetes, August 1, 2007; 56(8): 2046 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-X. Han, A. Chabowski, N. N. Tandon, J. Calles-Escandon, J. F. C. Glatz, J. J. F. P. Luiken, and A. Bonen Metabolic challenges reveal impaired fatty acid metabolism and translocation of FAT/CD36 but not FABPpm in obese Zucker rat muscle Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E566 - E575. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Holloway, A. B. Thrush, G. J. F. Heigenhauser, N. N. Tandon, D. J. Dyck, A. Bonen, and L. L. Spriet Skeletal muscle mitochondrial FAT/CD36 content and palmitate oxidation are not decreased in obese women Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1782 - E1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Tarnopolsky, C. D. Rennie, H. A. Robertshaw, S. N. Fedak-Tarnopolsky, M. C. Devries, and M. J. Hamadeh Influence of endurance exercise training and sex on intramyocellular lipid and mitochondrial ultrastructure, substrate use, and mitochondrial enzyme activity Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1271 - R1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Thyfault, M. G. Cree, D. Zheng, J. J. Zwetsloot, E. B. Tapscott, T. R. Koves, O. Ilkayeva, R. R. Wolfe, D. M. Muoio, and G. L. Dohm Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism Am J Physiol Cell Physiol, February 1, 2007; 292(2): C729 - C739. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Turpin, G. I. Lancaster, I. Darby, M. A. Febbraio, and M. J. Watt Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1341 - E1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Park, J. R. Berggren, M. W. Hulver, J. A Houmard, and E. P. Hoffman GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle Physiol Genomics, October 11, 2006; 27(2): 114 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chabowski, J. C. Chatham, N. N. Tandon, J. Calles-Escandon, J. F. C. Glatz, J. J. F. P. Luiken, and A. Bonen Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E675 - E682. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Collier, C. R. Bruce, A. C. Smith, G. Lopaschuk, and D. J. Dyck Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E182 - E189. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Beha, H.-P. Juretschke, J. Kuhlmann, C. Neumann-Haefelin, U. Belz, M. Gerl, W. Kramer, M. Roden, and A. W. Herling Muscle type-specific fatty acid metabolism in insulin resistance: an integrated in vivo study in Zucker diabetic fatty rats Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E989 - E997. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lin, M. Park, M. Hulver, and D. A. York Different metabolic responses to central and peripheral injection of enterostatin Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R909 - R915. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sriwijitkamol, C. Christ-Roberts, R. Berria, P. Eagan, T. Pratipanawatr, R. A. DeFronzo, L. J. Mandarino, and N. Musi Reduced Skeletal Muscle Inhibitor of {kappa}B{beta} Content Is Associated With Insulin Resistance in Subjects With Type 2 Diabetes: Reversal by Exercise Training Diabetes, March 1, 2006; 55(3): 760 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Aas, M. H. Rokling-Andersen, E. T. Kase, G. H. Thoresen, and A. C. Rustan Eicosapentaenoic acid (20:5 n-3) increases fatty acid and glucose uptake in cultured human skeletal muscle cells J. Lipid Res., February 1, 2006; 47(2): 366 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Benton, X.-X. Han, M. Febbraio, T. E. Graham, and A. Bonen Inverse relationship between PGC-1{alpha} protein expression and triacylglycerol accumulation in rodent skeletal muscle J Appl Physiol, February 1, 2006; 100(2): 377 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kiens Skeletal Muscle Lipid Metabolism in Exercise and Insulin Resistance Physiol Rev, January 1, 2006; 86(1): 205 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Berggren, M. W. Hulver, and J. A. Houmard Fat as an endocrine organ: influence of exercise J Appl Physiol, August 1, 2005; 99(2): 757 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
C L. Kien, J. Y Bunn, and F. Ugrasbul Increasing dietary palmitic acid decreases fat oxidation and daily energy expenditure Am. J. Clinical Nutrition, August 1, 2005; 82(2): 320 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-S. Cha, T. P. Ciaraldi, K.-S. Park, L. Carter, S. R. Mudaliar, and R. R. Henry Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPAR{gamma} agonists Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E151 - E159. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Hittel, Y. Hathout, E. P. Hoffman, and J. A. Houmard Proteome Analysis of Skeletal Muscle From Obese and Morbidly Obese Women Diabetes, May 1, 2005; 54(5): 1283 - 1288. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Thyfault, R. M. Kraus, R. C. Hickner, A. W. Howell, R. R. Wolfe, and G. L. Dohm Impaired plasma fatty acid oxidation in extremely obese women Am J Physiol Endocrinol Metab, December 1, 2004; 287(6): E1076 - E1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Pruchnic, A. Katsiaras, J. He, D. E. Kelley, C. Winters, and B. H. Goodpaster Exercise training increases intramyocellular lipid and oxidative capacity in older adults Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E857 - E862. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Bastie, T. Hajri, V. A. Drover, P. A. Grimaldi, and N. A. Abumrad CD36 in Myocytes Channels Fatty Acids to a Lipase-Accessible Triglyceride Pool That Is Related to Cell Lipid and Insulin Responsiveness Diabetes, September 1, 2004; 53(9): 2209 - 2216. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |